In the last period, **Progressive Corporation (PGR)** has seen heavy **investor interest**, with multiple firms initiating, increasing, or adjusting their stock positions. Investment firms such as **MBB Public Markets I LLC**, **Citi**, **American Trust**, **Caxton Associates LLP**, and **Challenger Wealth Management**, among many others, have invested significantly in Progressive. However, some organizations, such as **Ashton Thomas Private Wealth LLC** and **Goldman Sachs Group Inc**, have decreased their stakes. Despite some firms divesting their shares, Progressive's shares' **average price target** stands at **$284.18**. **July's impressive results**, marked by a **15% year-on-year rise in earned premiums**, has triggered interest in the biotech stock. A **dividend of $0.10 per share payable in October 2025** was declared by the corporation. **Wells Fargo** also reiterated their buy rating on the company's stock, set at a **$333 price target**. This intense interest from individual and institutional investors highlights the market's confidence in Progressive's continuous growth.
Progressive Corporation PGR News Analytics from Mon, 26 May 2025 07:00:00 GMT to Sat, 13 Sep 2025 23:24:06 GMT -
Rating 7
- Innovation 2
- Information 9
- Rumor 5
